Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.79 |
| ▸ | TSHR | P16473 | 4/20 | 0.73 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.73 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.73 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.70 |
| ▸ | MAPT | P10636 | 1/20 | 0.70 |
| ▸ | SLC22A6 | Q4U2R8 | 2/20 | 0.67 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.67 |
| ▸ | GPR84 | Q9NQS5 | 4/20 | 0.58 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.58 |
| ▸ | FFAR4 | Q5NUL3 | 2/20 | 0.58 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.58 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.58 |
| ▸ | CAMK2A | Q9UQM7 | 1/20 | 0.56 |
| ▸ | PPARG | P37231 | 4/20 | 0.55 |
| ▸ | PPARD | Q03181 | 4/20 | 0.55 |
| ▸ | PPARA | Q07869 | 4/20 | 0.55 |
| ▸ | HDAC11 | Q96DB2 | 3/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.55 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8843654 | 0.97 | TSHR (0.80) | LMNATSHRNFKB1PMP22KMT2A | |
| SCHEMBL11316452 | 0.97 | TSHR (0.80) | LMNATSHRNFKB1PMP22KMT2A | |
| SCHEMBL2349616 | 0.97 | TSHR (0.80) | LMNATSHRNFKB1PMP22KMT2A | |
| SCHEMBL25209921 | 0.97 | TSHR (0.80) | LMNATSHRNFKB1PMP22KMT2A | |
| SCHEMBL15013307 | 0.97 | TSHR (0.80) | LMNATSHRNFKB1PMP22KMT2A | |
| SCHEMBL25215828 | 0.97 | TSHR (0.80) | LMNATSHRNFKB1PMP22KMT2A | |
| SCHEMBL9680290 | 0.97 | TSHR (0.80) | LMNATSHRNFKB1PMP22KMT2A | |
| SCHEMBL8761235 | 0.97 | TSHR (0.80) | LMNATSHRNFKB1PMP22KMT2A | |
| SCHEMBL2580866 | 0.97 | TSHR (0.80) | LMNATSHRNFKB1PMP22KMT2A | |
| SCHEMBL8843674 | 0.97 | TSHR (0.80) | LMNATSHRNFKB1PMP22KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260115139-A1 | Amino Acid-Containing Ionizable Lipids for the Delivery of Therapeutic Agents | NANOVATION THERAPEUTICS INC. (CA) | 2026-04-30 | — | — | US | disclosed |
| EP-4594293-A1 | AMINO ACID-CONTAINING IONIZABLE LIPIDS FOR THE DELIVERY OF THERAPEUTIC AGENTS | Nanovation Therapeutics Inc. (CA) | 2025-08-06 | — | — | EP | disclosed |
| WO-2025035202-A1 | IONIZABLE LIPIDS COMPRISING MACROCYCLIC RINGS FOR THE DELIVERY OF THERAPEUTIC AGENTS | NANOVATION THERAPEUTICS INC. (CA) | 2025-02-20 | — | — | WO | disclosed |
| WO-2024065041-A1 | SULFUR-CONTAINING IONIZABLE LIPIDS FOR THE DELIVERY OF THERAPEUTIC AGENTS | NANOVATION THERAPEUTICS INC. (CA) | 2024-04-04 | — | — | WO | disclosed |
| WO-2024065043-A1 | AMINO ACID-CONTAINING IONIZABLE LIPIDS FOR THE DELIVERY OF THERAPEUTIC AGENTS | NANOVATION THERAPEUTICS INC. (CA) | 2024-04-04 | — | — | WO | disclosed |
| US-20090306134-A1 | Muscarinic receptor antagonists | THERAVANCE BIOPHARMA R&D IP, LLC | 2009-12-10 | — | — | US | disclosed |
| US-20090306134-A1 | Muscarinic receptor antagonists | THERAVANCE BIOPHARMA R&D IP, LLC | 2009-12-10 | — | — | US | disclosed |
| US-20090111737-A1 | Novel antibacterial agents | THERAVANCE BIOPHARMA ANTIBIOTICS IP, LLC | 2009-04-30 | — | — | US | disclosed |
| US-20090111737-A1 | Novel antibacterial agents | THERAVANCE BIOPHARMA ANTIBIOTICS IP, LLC | 2009-04-30 | — | — | US | disclosed |
| US-7456203-B2 | Muscarinic receptor antagonists | THERAVANCE, INC. (US) | 2008-11-25 | — | — | US | disclosed |
| EP-0347687-B1 | Biodegradable polyamide, films and products obtained from said polyamide and process for its preparation | SNIA TECNOPOLIMERI (IT) | 1995-09-06 | — | — | EP | disclosed |
| US-5140095-A | Incorporating a ketodicarboxylic acid | SNIA TECNOPOLIMERI S.P.A. (IT) | 1992-08-18 | — | — | US | disclosed |
| EP-0169033-B1 | INHIBITORS OF SLOW REACTING SUBSTANCE OF ANAPHYLAXIS | SCHERING CORPORATION (US) | 1992-02-12 | — | — | EP | disclosed |
| US-4988716-A | Inhibitors of slow reacting substance of anaphylaxis | SCHERING CORPORATION (US) | 1991-01-29 | — | — | US | disclosed |
| WO-1989012656-A1 | BIODEGRADABLE POLYAMIDE, FILMS AND PRODUCTS OBTAINED FROM SAID POLYAMIDE AND PROCESS FOR ITS PREPARATION | SNIA TECNOPOLIMERI S.P.A. (IT) | 1989-12-28 | — | — | WO | disclosed |
| EP-0347687-A1 | Biodegradable polyamide, films and products obtained from said polyamide and process for its preparation | CAFFARO S.p.A. (IT) | 1989-12-27 | — | — | EP | disclosed |
| US-4889873-A | Inhibitors of slow reacting substance of anaphylaxis | SCHERING CORPORATION (US) | 1989-12-26 | — | — | US | disclosed |
| US-4798842-A | Inhibitors of slow reacting substance of anaphylaxis | SCHERING CORPORATION (US) | 1989-01-17 | — | — | US | disclosed |
| US-4758594-A | Inhibitors of slow reacting substance of anaphylaxis | SCHERING CORPORATION (US) | 1988-07-19 | — | — | US | disclosed |
| EP-0169033-A2 | Inhibitors of slow reacting substance of anaphylaxis | SCHERING CORPORATION (US) | 1986-01-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260115139-A1 | Amino Acid-Containing Ionizable Lipids for the Delivery of Therapeutic Agents | SLC43A1, SLC7A1, SLC7A5 | LMNA 556/4885TSHR 1219/4885NFKB1 3789/4885 |
| US-20090306134-A1 | Muscarinic receptor antagonists | CHRM3, CHRM5, CHRM2 | LMNA 4772/4885TSHR 275/4885NFKB1 2313/4885 |
| US-20090111737-A1 | Novel antibacterial agents | ENGASE, PGLS, PEPD | LMNA 3115/4885TSHR 4185/4885NFKB1 3548/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.